- MicroVention started operations in Costa Rica in 2012, and is to invest US $80 million in a new 20,000-meter-squared plant.
The American-Japanese company, MicroVention-Terumo from the life sciences sector, announced that it will expand its operations in Costa Rica. With an investment of close to US $80 million by the end of 2022, it will build its new plant, measuring 20,000 square meters, in Coyol Free Zone in Alajuela and will soon generate 2,000 new jobs in administrative, operational and engineering areas. Currently, MicroVention employs 1,700 people.
In a recent visit to the company’s facilities, the President of the Republic, Carlos Alvarado, the Minister of Foreign Trade, Andrés Valenciano, and the General Director of CINDE, Jorge Sequeira, made the announcement.
President Alvarado, who weeks before had held a meeting with senior company officials, thanked them for their confidence in expanding their operations in the country and recognized how they are more than doubling the already large number of jobs they generate, which will benefit thousands of Costa Rican families.
After reiterating the government’s support for foreign direct investment and the Free Trade Zone Regime, Alvarado commented that, “this announcement by MicroVention, of increasing its payroll by 2000 jobs and opening a third plant, represents a great impact on the creation of quality employment in the country,” and highlighted the inter-institutional work that has been carried out, which will be strengthened with the new INA Law, in turn training Costa Ricans so that they have greater skills with which to enter the labor market.
“MicroVention began operations in Costa Rica more than 7 years ago and we recognize the great potential of our network of workers and managers, as well as manufacturing associates. Our success in Costa Rica has allowed MicroVention to grow in what is our third expansion in the country. Today, our strategic vision is driving us to close 2022 with nearly 35,000 square meters of manufacturing facilities and 3,000 employees. We are very proud to be exporting medical products from Costa Rica to all over the world as well as helping patients have a better quality of life,” said Charlie Noel, Vice President of International Operations at MicroVention.
The Minister of Foreign Trade, Andrés Valenciano, was pleased with the announcement and indicated, “It is great news that leading companies, such as MicroVention, continue to bet on Costa Rica. Today, we celebrate the creation of 2,000 new and important jobs, which translates into growth and well-being for many Costa Rican families. In addition, it shows how reinvestments continue to be a source of development opportunities for the country, where democratic stability, legal security and our values are, without a doubt, key components of our value proposition. For the Government of Costa Rica, this news furthers the great commitment to working hard to create the right conditions for companies like this to continue growing. Many congratulations and my deepest gratitude for the trust placed in the country.”
In Costa Rica, the company has two manufacturing plants dedicated to creating medical devices used in endovascular therapies for the treatment of vascular and brain diseases.
Jorge Sequeira Picado, General Director of CINDE, said: “The expansion of MicroVention in Costa Rica confirms that multinational companies are committed to the planet, its people and the prosperity equation, and that, furthermore, they seek to invest with purpose and come to a country that offers a strategic ally to achieve their goals. This investment is a clear reflection of how the country is also an ideal destination for nearshoring strategies that many companies are implementing in order to bring their production closer to target markets such as the United States. This company in the life sciences sector shows that medical devices continue to be Costa Rica’s main exports. We congratulate MicroVention for this investment, and foresee huge returns from our valuable human talent.”
For those interested in applying, the company will shortly be announcing via official channels job opportunities within the new plant.
At the moment, some positions are open in the company and they can be viewed here: https://www.microvention.com/chapla/jobs
Founded in 1997, MicroVention develops and markets medical devices that enable or significantly enhance the treatment of cerebrovascular diseases. In 2006, Terumo Corporation, a major global medical device company based in Tokyo, Japan, welcomed MicroVention into its family of companies. Terumo’s acquisition of MicroVention enabled both companies to leverage their unique and patented technologies toward a greater focus on treating cerebrovascular diseases.
Based in California, MicroVention products are sold in more than 75 countries through a direct sales organization in conjunction with strategic distribution partnerships.